Eli Lilly and Company LLY

NYSE US Health Care Pharmaceuticals

$1,412.97 ▲ +0.07% (+$1.02)

Index member: S&P 500

Open $1,415.83

Prev Close $1,411.95

Day Range $1,400.00 – $1,420.42

52W Range $850.51 – $1,453.00

Market Cap $1.33T

P/E (TTM) 46.19

Beta 0.39

Div Yield 0.75%

EPS (TTM) $30.81

📋 Company Profile

Industry	Pharmaceuticals
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1970-07-09
Shares Out.	940,750,000
Website	lilly.com/ ↗
Phone	13172762000
Employees	50,000
Revenue	$24.40B
Gross Profit	$20.46B
Net Income	$6.45B
Free Cash Flow	$19.66B
Total Assets	$148.07B
Total Liabilities	$107.80B
Equity	$40.27B

About Eli Lilly and Company

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly and Company is a publicly traded company under the ticker symbol LLY on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.